West Family Investments’s GSK GSK Stock Holding History

West Family Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Sell	5,776 -770	-12%	-$40.7K	0.09%	335
2026 Q1	$361K	Sell	6,546 -3,643	-36%	-$197K	0.13%	150
2025 Q4	$500K	Hold	10,189	–	–	0.12%	165
2025 Q3	$440K	Buy	10,189 +70	+0.7%	+$2.73K	0.1%	215
2025 Q2	$389K	Buy	10,119 +3,573	+55%	+$137K	0.1%	215
2025 Q1	$254K	Sell	6,546 -1,704	-21%	-$62.4K	0.1%	196
2024 Q4	$279K	Buy	8,250 +2,470	+43%	+$88.9K	0.1%	205
2024 Q3	$236K	Buy	+5,780	New	+$236K	0.08%	246
2022 Q3	–	Sell	-9,457	Closed	-$515K	–	233
2022 Q2	$515K	Buy	9,457 +138	+1%	+$7.62K	0.2%	92
2022 Q1	$507K	Hold	9,319	–	–	0.14%	110
2021 Q4	$514K	Sell	9,319 -1,144	-11%	-$59.5K	0.14%	121
2021 Q3	$500K	Buy	10,463 +918	+10%	+$46.1K	0.13%	138
2021 Q2	$475K	Buy	+9,545	New	+$459K	0.13%	138

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

West Family Investments's GSK Position: Q2 2026 in Review

West Family Investments reduced its GSK (GSK) stake by 12% in Q2 2026, selling an estimated $40.7K and leaving 5,776 shares worth $303K. The position accounts for 0.09% of the portfolio, ranked #335.

West Family Investments first reported a position in GSK in Q2 2021 and has held it in 13 quarters since. The position peaked at $515K in Q2 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

West Family Investments held 5,776 shares of GSK worth $303K as of Q2 2026.
West Family Investments sold 770 GSK shares in Q2 2026, an estimated $40.7K.
GSK made up 0.09% of West Family Investments's portfolio in Q2 2026, its #335 holding.
West Family Investments first reported a position in GSK in Q2 2021 and has held it in 13 quarters since.
West Family Investments's GSK position peaked at $515K in Q2 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.